Buscar
Mostrando ítems 1-10 de 139
Immunomodulatory monoclonal antibodies in combined immunotherapy trials for cutaneous melanoma
(Frontiers Media S.A., 2017-08)
In the last few years, there has been a twist in cancer treatment toward immunotherapy thanks to the impressive results seen in advanced patients from several tumor pathologies. Cutaneous melanoma is a highly mutated and ...
Uso do ipilimumabe em pacientes com melanoma metastático
(Universidade Estadual Paulista (Unesp), 2018-07-12)
HENRIQUES, V. S. Uso do ipilimumabe em pacientes com melanoma metastático. 2018. 24 f. Dissertação (Mestrado em Pesquisa Clínica) – Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, 1999. O ...
Factores de riesgo para melanoma lentiginoso acral: un estudio de casos y controles en población colombiana
RESUMEN
En Colombia se presentan casi 1000 casos nuevos de melanomas en todas las
localizaciones, representando ademàs cerca del 10% de todos los cánceres de piel
que se atienden en el Instituto Nacional de Cancerología, ...
Mutaciones de KIT, NRAS y BRAF en melanomaKIT, NRAS and BRAF mutations in melanoma
(Asociación Colombiana de Dermatología y Cirugía DermatológicaCentro de de Investigaciones DermatológicasBogotá, Colombia, 2022)
Combining immunotherapy with oncogene-targeted therapy: A new road for melanoma treatment
(Frontiers Research Foundation, 2015-02)
Cutaneous melanoma arises from the malignant transformation of skin melanocytes; its incidence and mortality have been increasing steadily over the last 50 years, now representing 3% of total tumors. Once melanoma metastasizes, ...
Structure-function analysis and therapeutic efficacy of antibodies to fungal melanin for melanoma radioimmunotherapy
(2018)
Metastatic melanoma remains difficult to treat despite recent approvals of several new drugs. Recently we reported encouraging results of Phase I clinical trial of radiolabeled with 188Re murine monoclonal IgM 6D2 to melanin ...
Understanding current therapies in metastatic melanoma
(SOC MEDICA SANTIAGO, 2016)
Cutaneous melanoma is a highly aggressive tumor developing from melanocytes, its incidence is increasing, and prognosis in advanced stages is daunting. New therapies have been approved during the recent years with unprecedented ...
TAPcells, the Chilean dendritic cell vaccine against melanoma and prostate cancer
(2013)
Here we summarize 10 years of effort in the development of a biomedical innovation with global projections. This innovation consists of a novel method for the production of therapeutic dendritic-like cells called Tumor ...